FAZIO, CAROLINA
 Distribuzione geografica
Continente #
NA - Nord America 1.144
EU - Europa 955
AS - Asia 413
SA - Sud America 67
AF - Africa 7
Totale 2.586
Nazione #
US - Stati Uniti d'America 1.130
RU - Federazione Russa 297
SG - Singapore 188
IE - Irlanda 152
IT - Italia 149
GB - Regno Unito 133
CN - Cina 126
BR - Brasile 62
DE - Germania 51
SE - Svezia 47
UA - Ucraina 35
HK - Hong Kong 32
VN - Vietnam 26
FR - Francia 25
FI - Finlandia 21
ES - Italia 16
KR - Corea 10
IN - India 9
MX - Messico 7
ZA - Sudafrica 6
AT - Austria 5
CA - Canada 4
CH - Svizzera 4
JP - Giappone 4
PL - Polonia 4
BD - Bangladesh 3
BE - Belgio 3
EC - Ecuador 3
LT - Lituania 3
TR - Turchia 3
OM - Oman 2
SA - Arabia Saudita 2
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
NL - Olanda 1
PA - Panama 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.586
Città #
Fairfield 155
Dublin 153
Singapore 117
Southend 112
Dallas 104
Ashburn 91
Moscow 87
Woodbridge 83
Cambridge 63
Houston 59
Santa Clara 58
Seattle 57
Wilmington 57
Beijing 49
New York 43
Hong Kong 32
Jacksonville 30
Chandler 27
Ann Arbor 25
Siena 24
Princeton 21
Munich 20
Los Angeles 18
Milan 14
Shanghai 14
Hefei 13
Helsinki 12
Málaga 12
Dong Ket 11
San Diego 11
San Mateo 11
Florence 10
Seoul 10
Borgo San Lorenzo 8
Brooklyn 7
Dearborn 6
Denver 6
San Francisco 6
Turku 6
Boston 5
Buffalo 5
Fremont 5
Johannesburg 5
Nanjing 5
Redondo Beach 5
San Giovanni Valdarno 5
Stockholm 5
São Paulo 5
Düsseldorf 4
Hanoi 4
Ho Chi Minh City 4
Hounslow 4
Labico 4
Orem 4
Palermo 4
Phoenix 4
Poplar 4
Redwood City 4
The Dalles 4
Tokyo 4
Venezia 4
Zurich 4
Asciano 3
Atlanta 3
Brussels 3
Empoli 3
Lavis 3
Montreal 3
Mumbai 3
Nuremberg 3
Querétaro 3
Rome 3
Warsaw 3
Altamura 2
Boardman 2
Changsha 2
Charlotte 2
Chiusdino 2
Columbus 2
Council Bluffs 2
Guangzhou 2
Guayaquil 2
Itamaraju 2
Jacareí 2
Lauterbourg 2
London 2
Mexico City 2
Perugia 2
Pistoia 2
Portsmouth 2
Rio de Janeiro 2
Salerno 2
Secaucus 2
Sesto Fiorentino 2
São Leopoldo 2
Trieste 2
Vienna 2
Amparo 1
Amsterdam 1
Aparecida de Goiânia 1
Totale 1.827
Nome #
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme 313
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: Results of a phase II study 284
Immunomodulatory properties of DNA hypomethylating agents: Selecting the optimal epigenetic partner for cancer immunotherapy 233
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016 218
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival 217
Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial 199
“Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015 194
Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models 189
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017 187
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 143
ICOS expression as immunologic marker in immune activating monoclonal antibodies 137
“Cancer Bio-Immunotherapy in Siena”: Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9–11, 2014 121
Safety and immunobiological activity of guadecitabine sequenced with ipilimumab in metastatic melanoma patients: The phase Ib NIBIT-M4 study 104
Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: An open-label, single-arm, phase 2 study 76
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets 27
Totale 2.642
Categoria #
all - tutte 8.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021195 0 0 0 0 0 31 15 45 14 42 13 35
2021/2022177 8 34 17 6 8 10 10 6 3 19 28 28
2022/2023180 13 10 28 14 12 32 8 14 21 14 8 6
2023/2024254 9 4 32 7 11 82 84 4 5 0 10 6
2024/2025406 14 14 46 18 52 27 5 20 50 21 39 100
2025/2026774 67 116 84 164 338 5 0 0 0 0 0 0
Totale 2.642